Literature DB >> 3440823

Evidence against benefit from replacement doses of thyroid hormones in nonthyroidal illness (NTI): studies using turpentine oil-injected rat.

I J Chopra1, T S Huang, R Boado, D H Solomon, G N Chua Teco.   

Abstract

Sprague-Dawley rats were treated with saline or turpentine oil (5 mu 1/g bw sc at 3-day intervals x3) with or without replacement doses of T4 (0.8 g/100 g bw/day ip) or T3(0.3 microgram/100 g bw/day ip). Injection of turpentine oil to the rat consistently caused a significant reduction in serum total T4, total T3, free T4 index and TSH. Despite marked changes in thyroidal economy in experimental rat, iodothyronine 5'-monodeiodinating activity (MA) in the liver, the kidney and the hearth and the hepatic alpha-glycerophosphate dehydrogenase activity were decreased inconsistently and when decreased, the various enzyme activities were not influenced appreciably by treatment with replacement doses of T4 or T3. Cerebral cortical T4 5-MA was normal or increased in the turpentine oil-injected rat. Dermal T4 5-MA was decreased in the turpentine oil-injected rat and replacement doses of thyroid hormones did not normalize it. Urinary excretion of urea nitrogen was normal in the turpentine oil-injected rat and did not change appreciably after treatment with thyroid hormones. Our data suggest that replacement doses of thyroid hormones are not beneficial to a host with altered thyroid economy during a systemic illness.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3440823     DOI: 10.1007/BF03346994

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  24 in total

1.  Effect of tri-iodothyronine replacement on the metabolic and pituitary responses to starvation.

Authors:  D F Gardner; M M Kaplan; C A Stanley; R D Utiger
Journal:  N Engl J Med       Date:  1979-03-15       Impact factor: 91.245

2.  Hypermetabolic low triiodothyronine syndrome of burn injury.

Authors:  R A Becker; G M Vaughan; M G Ziegler; L G Seraile; I W Goldfarb; E H Mansour; W F McManus; B A Pruitt; A D Mason
Journal:  Crit Care Med       Date:  1982-12       Impact factor: 7.598

3.  An improved radioimmunoassay of triiodothyronine in serum: its application to clinical and physiological studies.

Authors:  I J Chopra; R S Ho; R Lam
Journal:  J Lab Clin Med       Date:  1972-11

4.  A study of extrathyroidal conversion of thyroxine (T4) to 3,3',5-triiodothyronine (T3) in vitro.

Authors:  I J Chopra
Journal:  Endocrinology       Date:  1977-08       Impact factor: 4.736

5.  Skin is an active site for the inner ring monodeiodination of thyroxine to 3,3',5'-triiodothyronine.

Authors:  T S Huang; I J Chopra; A Beredo; D H Solomon
Journal:  Endocrinology       Date:  1985-11       Impact factor: 4.736

6.  The effect of T3 and reverse T3 administration on muscle protein catabolism during fasting as measured by 3-methylhistidine excretion.

Authors:  K D Burman; L Wartofsky; R E Dinterman; P Kesler; R W Wannemacher
Journal:  Metabolism       Date:  1979-08       Impact factor: 8.694

7.  Treatment of dopamine-dependent shock with triiodothyronine.

Authors:  R D Hesch; M Hüsch; R Ködding; B Höffken; T Meyer
Journal:  Endocr Res Commun       Date:  1981

8.  Effect of thyroid hormone supplementation on survival after bacterial infection.

Authors:  J S Little
Journal:  Endocrinology       Date:  1985-10       Impact factor: 4.736

Review 9.  Thyroid function in nonthyroidal illnesses.

Authors:  I J Chopra; J M Hershman; W M Pardridge; J T Nicoloff
Journal:  Ann Intern Med       Date:  1983-06       Impact factor: 25.391

10.  Thyroid function in a uremic rat model. Evidence suggesting tissue hypothyroidism.

Authors:  V S Lim; C Henriquez; H Seo; S Refetoff; E Martino
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

View more
  4 in total

Review 1.  The euthyroid sick syndrome: is there a physiologic rationale for thyroid hormone treatment?

Authors:  N Stathatos; L Wartofsky
Journal:  J Endocrinol Invest       Date:  2003-12       Impact factor: 4.256

Review 2.  Reawakened interest in type III iodothyronine deiodinase in critical illness and injury.

Authors:  Stephen A Huang; Antonio C Bianco
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-01-22

3.  Serum thyroid hormones levels are significantly decreased in septic neonates with poor outcome.

Authors:  A Kurt; A D Aygun; I Sengul; Y Sen; A N Citak Kurt; B Ustundag
Journal:  J Endocrinol Invest       Date:  2010-09-09       Impact factor: 4.256

4.  The Changes of Thyroid Function and Related Factors in Critical Patients without Thyroid Illness in ICU: A Retrospective Cross-Sectional Study.

Authors:  Jiang-Nan Zhang; Xi-Le Zhao
Journal:  Ther Clin Risk Manag       Date:  2022-05-16       Impact factor: 2.755

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.